Recently, Grindelwald (Grnd) has been identified as a novel tumor necrosis factor receptor (TNFR) mediating RasV12/scrib−/−-induced tumor growth and invasion (Andersen et al., 2015). Here, TNFRSF1A is linked to neoplasm.